BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 16, 2019
View Archived Issues
Buying time for therapy salvages lungs for transplant
Read More
Dynein axonemal heavy chain family identified as chemosensitivity-related genes in gastric cancer
Read More
Study confirms the oncogenic role of CDC20 in primary cutaneous squamous cell carcinoma
Read More
RPN2 as a biomarker to predict the outcome of chemotherapy for advanced gastric cancer
Read More
Small-molecule enhancers of E3 ligase-substrate interaction induce mutant beta-catenin degradation
Read More
A novel NOTCH3 mutation associated with epilepsy as an early manifestation of CADASIL
Read More
Surfactant protein D restricts HIV-1 passage across vaginal barrier in preclinical models
Read More
Tafazzin gene therapy created to treat Barth syndrome
Read More
InFlectis BioScience announces phase I results for IFB-088
Read More
Bispecific anti-VEGF/ANG-2 surrobody SL-634 shows potential to treat wet AMD
Read More
Vertex and Kymera enter strategic research and development collaboration
Read More
GABA-selective AAV therapy upregulates SCN1A to treat Dravet syndrome
Read More
New stroke therapy promotes motor recovery in mice
Read More
Bayer describes new P2X purinoceptor 3 antagonists
Read More
FORMA Therapeutics discloses new HDAC6 inhibitors
Read More
New phase I trial studies MK-8558 in antiretroviral-naive patients with HIV-1
Read More
FDA approves Venclexta with Gazyva for previously untreated CLL or SLL
Read More
FDA clears IND for Turning Point's TPX-0022
Read More
Emory University synthesizes fusion peptides including uPA or EGFR sequences with a toxin
Read More
Phase I/II results of DNase eye drops for dry eye disease
Read More
Vernalis, Servier present Bcl-2 inhibitors
Read More
New TrpC6 antagonists discovered by Hydra Biosciences and Boehringer Ingelheim
Read More
NCI studies whether Lixte's LB-100 can penetrate glioblastoma multiforme tumors
Read More
M.D. Anderson studies anti-PR1/HLA-A2 monoclonal antibody Hu8F4 in advanced hematologic malignancies
Read More